newsfilter
← Latest News
GlobeNewswire·

NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine

In advance of November 10, 2026, GDUFA goal date, all requested changes were classified as "MINOR."NRx was requested to prepare and submit labels with the proprietary name currently under review by FDA.NRx is